Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY10.01 CNY
Change Today +0.06 / 0.60%
Volume 1.8M
600829 On Other Exchanges
As of 3:05 AM 09/30/15 All times are local (Market data is delayed by at least 15 minutes).

hpgc renmintongtai pharmac-a (600829) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/18/15 - CNY29.00
52 Week Low
09/15/15 - CNY8.79
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HPGC RENMINTONGTAI PHARMAC-A (600829)

Related News

No related news articles were found.

hpgc renmintongtai pharmac-a (600829) Related Businessweek News

No Related Businessweek News Found

hpgc renmintongtai pharmac-a (600829) Details

HPGC Renmintongtai Pharmaceutical Corporation produces and sells OTC products and prescription drugs in China and internationally. It primarily produces and manages Chinese and western medicine in various dosage forms, including small volume injections, oral liquids, oral solutions, mixtures, aerosol, pills, dropping pills, raw medicines, sterile raw medicines, powder injections, little capacity injections, tablets, capsules, lotions, granules, spraying agents, freeze-dried injections, lyophilization injections, creams and ointments, eye drops, and other products. The company is also involved in the wholesale of chemical preparations, Chinese patent medicine, antibiotics, biochemical medicine, chemical raw medicine, narcotics, and psychotropic drugs; and health foods. In addition, it imports and exports goods and technologies, as well as is involved in other businesses. The company was formerly known as Harbin Pharm Group Sanjing Pharmaceutical Shareholding Co., Ltd. and changed its name to HPGC Renmintongtai Pharmaceutical Corporation in April 2015. HPGC Renmintongtai Pharmaceutical Corporation was founded in 1950 and is based in Harbin, China.

Founded in 1950

hpgc renmintongtai pharmac-a (600829) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hpgc renmintongtai pharmac-a (600829) Key Developments

HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Six Months of 2015

HPGC Renmintongtai Pharmaceutical Corporation reported earnings results for the first six months of 2015. For the period, the company reported basic earnings per share were CNY 0.1802. Weighted average return on net assets was 3.50%.

HPGC Renmintongtai Pharmaceutical Corporation to Report First Half, 2015 Results on Aug 15, 2015

HPGC Renmintongtai Pharmaceutical Corporation announced that they will report first half, 2015 results on Aug 15, 2015

HPGC Renmintongtai Pharmaceutical Corporation, Board Meeting, May 29, 2015

HPGC Renmintongtai Pharmaceutical Corporation, Board Meeting, May 29, 2015. Agenda: To discuss and approve the proposal of adjustment of prediction of daily connected transactions in 2015; to discuss and approve the proposal of applying for entrust loan to Harbin Pharmaceutical Group Co., Ltd.; and to discuss and approve the proposal of amending 'rules of order for shareholders' meeting' and other corporate governance systems.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600829:CH CNY10.01 CNY +0.06

600829 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600829.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600829 Industry Range
Price/Earnings 100.0x
Price/Sales 3.0x
Price/Book 4.1x
Price/Cash Flow 360.5x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HPGC RENMINTONGTAI PHARMAC-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at